Not Yet Recruiting OBSERVATIONAL NCT06378489

The Use of Etonogestrel Contraceptive Implant as Treatment for Endometrial Hyperplasia Without Atypia: A Cohort Study

The Etonogestrel Contraceptive Implant for Treatment of Endometrial Hyperplasia Without Atypia: A Single-arm, Open-label, Longitudinal Study in a Government Hospital in the Philippines

Sponsor: Organon

Conditions Endometrial Hyperplasia Without Atypia

Interventions Etonogestrel implant

Updated 3 times since 2024 Last updated: Apr 17, 2024 Started: Jun 1, 2024 Primary completion: Jan 31, 2025 Completion: May 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Endometrial Hyperplasia Without Atypia and is currently actively recruiting participants. Organon leads this study, which shows 3 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Not Yet Recruiting
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting
May 2024 — Jul 2024 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Organon
University of the Philippines

Data source: University of the Philippines

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.